Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344838 · ClinicalTrials.gov registry record
Customized Laser Ablation: Comparing Results of LADAR Vision and VISX Platforms
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 458
- Enrollment target
NCT00344838: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT00344838 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 458 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00344838 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 458 participants
- Enrollment target
Study Summary
To compare the results of two commercially available customized laser ablation devices.
Primary Outcome
Visual Acuity aberration pre-and post-treatment
Interventions
- DEVICE Comparison of LADAR CustomLasik and VISX Wavefront System custom laser ablation devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2003-09 |
| Est. Completion | 2017-10-30 |
What the finished NCT00344838 record still lists
NCT00344838 is an observational study that tracks outcomes without assigning an intervention. The registered 458 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Comparison of LADAR CustomLasik and VISX Wavefront System custom laser ablation devices is the first listed.
NCT00344838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00344838 about?
NCT00344838 is a clinical study titled "Customized Laser Ablation: Comparing Results of LADAR Vision and VISX Platforms". To compare the results of two commercially available customized laser ablation devices.
What is the current status of trial NCT00344838?
This trial is currently completed. The enrollment target is 458 participants. The study started on 2003-09. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT00344838?
The interventions under investigation include: Comparison of LADAR CustomLasik and VISX Wavefront System custom laser ablation devices (DEVICE).
Who is sponsoring clinical trial NCT00344838?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05856942 · 458 participants · NA
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
- NCT06201676 · 458 participants · Phase 4
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia